This study evaluated the level of susceptibility of monocytes and lymphocytes to spontaneously induced and CH11-induced apoptosis in 16 patients with Brucella infection. The expression of some immunological and apoptotic markers was evaluated. Before therapy, monocytes showed a high level of resistance to spontaneously induced or CH11-induced apoptosis in all patients. In patients with acute infection, this resistance persisted for 10-20 days after treatment was initiated, then decreased; in chronically infected patients, it persisted after 45 days of treatment. Lymphocytes were also more resistant to CH 11-induced apoptosis. The level of activated CD8++ T lymphocytes was high in patients with acute infection. The data indicate that the CD95-mediated apoptotic pathway is not involved in CH11 resistance. Lymphocytes are not infected by Brucella, so their resistance to apoptosis may be due to a soluble factor released by infected monocytes. The evaluation of levels of susceptibility to CH11-induced apoptosis in monocytes may be used to test the effectiveness of the therapy.

Tolomeo M., Di Carlo P., Abbadessa V., Titone L., Miceli S., Barbusca E., et al. (2003). Monocyte and lymphocyte apoptosis resistance in acute and chronic brucellosis and its possible implications in clinical management. CLINICAL INFECTIOUS DISEASES, 36(12), 1533-1538 [10.1086/375223].

Monocyte and lymphocyte apoptosis resistance in acute and chronic brucellosis and its possible implications in clinical management

Di Carlo P.;Abbadessa V.;Barbusca E.;Arista S.;Scarlata F.
2003

Abstract

This study evaluated the level of susceptibility of monocytes and lymphocytes to spontaneously induced and CH11-induced apoptosis in 16 patients with Brucella infection. The expression of some immunological and apoptotic markers was evaluated. Before therapy, monocytes showed a high level of resistance to spontaneously induced or CH11-induced apoptosis in all patients. In patients with acute infection, this resistance persisted for 10-20 days after treatment was initiated, then decreased; in chronically infected patients, it persisted after 45 days of treatment. Lymphocytes were also more resistant to CH 11-induced apoptosis. The level of activated CD8++ T lymphocytes was high in patients with acute infection. The data indicate that the CD95-mediated apoptotic pathway is not involved in CH11 resistance. Lymphocytes are not infected by Brucella, so their resistance to apoptosis may be due to a soluble factor released by infected monocytes. The evaluation of levels of susceptibility to CH11-induced apoptosis in monocytes may be used to test the effectiveness of the therapy.
Tolomeo M., Di Carlo P., Abbadessa V., Titone L., Miceli S., Barbusca E., et al. (2003). Monocyte and lymphocyte apoptosis resistance in acute and chronic brucellosis and its possible implications in clinical management. CLINICAL INFECTIOUS DISEASES, 36(12), 1533-1538 [10.1086/375223].
File in questo prodotto:
File Dimensione Formato  
apoptosis brucella.15.pdf

Solo gestori archvio

Tipologia: Versione Editoriale
Dimensione 124.47 kB
Formato Adobe PDF
124.47 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/10447/433567
Citazioni
  • ???jsp.display-item.citation.pmc??? 13
  • Scopus 35
  • ???jsp.display-item.citation.isi??? 28
social impact